Nutraceuticals CDMO Market to grow with a CAGR of 7.87% through 2029
Growing demand of development of the
nutraceutical products and to ensure the quality standard are factors driving
the growth of Global Nutraceuticals CDMO Market in the forecast period,
2025-2029.
According to TechSci Research report, “Nutraceuticals CDMO Market
–Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2029F”, the
Global Nutraceuticals CDMO Market stood at USD 34.09 Billion in 2023 and is
anticipated to projected at an impressive CAGR 7.87% growth in the forecast
period through 2029. This can be ascribed to collaborations and partnerships
among leading companies with a diverse approach to merge the expertise of
individual companies and to strengthen their position in the market.
The nutraceuticals CDMO market is
heavily influenced by regulatory frameworks and quality assurance standards
governing the production, labeling, and marketing of nutraceutical products.
Regulatory support plays a crucial role in providing assurance to consumers
regarding the safety, efficacy, and quality of the products they purchase. Many
governments worldwide have established regulatory agencies, such as the Food
and Drug Administration (FDA) in the United States and the European Food Safety
Authority (EFSA) in the European Union, to oversee the nutraceuticals industry
and ensure compliance with established standards. These regulations encompass
various aspects, including good manufacturing practices (GMP), labeling
requirements, and permissible ingredients and dosages.
Regulatory bodies continuously update
and revise existing regulations to reflect advances in scientific research,
technological innovation, and emerging safety concerns. This creates a dynamic
regulatory environment that necessitates ongoing compliance and adaptation by
nutraceutical CDMOs to meet evolving standards and requirements. Adherence to
quality assurance protocols and certification programs, such as ISO 9001, NSF
International, and US Pharmacopeia (USP), demonstrates a commitment to product
quality, safety, and consistency. These certifications enhance the credibility
and trustworthiness of nutraceutical companies in the eyes of consumers and
regulatory authorities alike.
Regulatory support for
health claims and functional ingredients further drives innovation and market
growth within the nutraceuticals industry. Governments may authorize specific
health claims based on scientific evidence supporting the beneficial effects of
certain nutrients or bioactive compounds on human health, thereby encouraging
the development and marketing of related products by nutraceutical CDMOs.
Ingredient sourcing and supply chain disruptions can present significant challenges to the Global Nutraceutical CDMO (Contract Development and Manufacturing Organization) market. The nutraceutical industry relies on a diverse range of raw materials, including botanicals, extracts, vitamins, minerals, and other bioactive compounds. The reliability and consistency of ingredient suppliers can vary, affecting the quality and availability of essential components for nutraceutical formulations. Many nutraceutical ingredients are derived from natural sources and may be subject to seasonal variations in availability and quality. This can lead to challenges in maintaining consistent product formulations and meeting production timelines.
Browse over XX market data Figures and
spread through XX Pages and an in-depth TOC on "Global Nutraceuticals CDMO Market”
The Global Nutraceuticals CDMO Market
segmentation is based on dosage form, service, company size, regional
distribution and company.
Based on company size, In the forecast period for the Global
Nutraceuticals Contract Development and Manufacturing Organization (CDMO)
Market, mid-sized companies are anticipated to dominate. While large companies
may possess substantial resources and established infrastructures, mid-sized
companies often offer a balance of flexibility, agility, and expertise that
enables them to effectively cater to the dynamic needs of the nutraceuticals
industry. Mid-sized companies typically have the
capacity to innovate and adapt quickly to changing market trends, allowing them
to capitalize on emerging opportunities and address niche segments within the
nutraceuticals market. Their streamlined organizational structures and less
bureaucratic processes facilitate faster decision-making and execution,
enabling them to remain competitive in a rapidly evolving landscape. Mid-sized
companies often specialize in niche areas or provide specialized services
within the nutraceuticals CDMO market, allowing them to differentiate
themselves and carve out a distinct market position. This specialization
enables them to deliver tailored solutions and high-quality services that meet
the unique requirements of their clients, driving customer satisfaction and
loyalty. Mid-sized companies may form strategic
partnerships or collaborations with larger corporations or research
institutions to leverage complementary strengths and resources, further
enhancing their competitive advantage and market presence.
North America's anticipated dominance in
the forecast period of the Global Nutraceuticals Contract Development and
Manufacturing Organization (CDMO) Market can be attributed to several factors. North America has a strong consumer demand
for nutraceutical products, fueled by increasing awareness of health and
wellness, rising disposable incomes, and a growing aging population. Consumers
in the region are increasingly turning to dietary supplements, functional
foods, and other nutraceutical products to address various health concerns and
improve overall well-being. Favorable regulatory frameworks and supportive
government policies in North America facilitate market growth and investment in
the nutraceuticals CDMO sector. Regulatory agencies such as the Food and Drug
Administration (FDA) in the United States provide clear guidelines and
oversight, ensuring product safety and quality while also fostering innovation
and market expansion.
Some of the major companies operating in the Global Nutraceuticals CDMO Market
include:
·
Catalent
Inc.
·
Lonza
Group AG
·
NUTRASCIENCE
LABS Inc
·
Robinson
Pharma, Inc.
·
Health
Wright Products, Inc.
·
Innovations
in Nutrition + Wellness
·
INPHARMA
S.p.A.
·
Aenova
Group
·
NutraPakUSA
·
SFI
Health Pty Ltd.
Download Free Sample Report
Customers can also request for 10% free
customization on this report
“Functional foods and beverages, which
offer health benefits beyond basic nutrition, are gaining popularity among
consumers seeking convenient and effective ways to improve their well-being.
This trend is driving demand for nutraceutical ingredients that can be
incorporated into a wide range of food and beverage products, including
fortified snacks, beverages, dairy products, and meal replacements. CDMOs are capitalizing on this trend by
expanding their capabilities to develop and manufacture functional ingredients
and finished products for food and beverage companies. By collaborating with
food scientists, nutritionists, and culinary experts, CDMOs can create
innovative formulations that combine nutritional benefits with great taste and
convenience. This enables food and beverage brands to differentiate themselves
in the market and meet the evolving needs of health-conscious consumers", said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based Global management
consulting firm.
"Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Tablets & Capsules, Powder, Softgel, Others), By Service (Product Formulation and Development, Manufacturing and Packaging, Research & Development (R&D), Regulatory Compliance, Others), By Company Size (Small Companies, Mid-Sized Companies, Large Companies), By Region, and Competition, 2019-2029F” has evaluated the future growth
potential of Global Nutraceuticals CDMO Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global Nutraceuticals CDMO Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com